A stool culture is more likely to be ordered when a person: 1  Has severe symptoms, dehydration, electrolyte imbalance, and/or other complications. 2  Is very young, elderly, or has a weakened immune system; according to the Centers for Disease Control and Prevention (CDC), diarrhea is a global killer.
Where will Horizon Pharma's stock price be in 2018? 11 equities research analysts have issued 12-month price targets for Horizon Pharma's stock. Their predictions range from $13.00 to $30.00. On average, they expect Horizon Pharma's share price to reach $19.18 in the next twelve months. View Analyst Ratings for Horizon Pharma.
Kite Pharma Reaches Analyst Target Price. In recent trading, shares of Kite Pharma Inc (Symbol: KITE) have crossed above the average analyst 12-month target price of $70.82, changing hands for $79.62/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.